Advertisement
Advertisement
CLRB
Cellectar Biosciences INC NEW
2.60
USDSponsored
+0.03
+1.17%
Aug 10, 15:59 UTC -4
Closed
After-Market
2.58
-0.02
-0.58%
CLRB Earnings Reports
Positive Surprise Ratio
CLRB beat 21 of 40 last estimates.
53%
Next Report
In 2 Days
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.49
Implied change from Q1 26 (Revenue/ EPS)
--
/-62.31%
Implied change from Q2 25 (Revenue/ EPS)
--
/-85.55%
Cellectar Biosciences INC NEW earnings per share and revenue
On May 14, 2026, CLRB reported earnings of -1.30 USD per share (EPS) for Q1 26, beating the estimate of -1.92 USD, resulting in a 32.39% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.49 USD, with revenue projected to reach -- USD, implying an decrease of -62.31% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Veru Inc.
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.30
Surprise
+8.09%
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-Actual
$0.16
Surprise
-
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
CeriBell, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.48
Actual
-$0.51
Surprise
-6.10%
Varex Imaging Corporation Common Stock
Report Date
Aug 10, 2026 For Q3 26
Estimate
$0.21
Actual
$0.31
Surprise
+44.93%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
Village Farms International, Inc. Common Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.02
Actual
$0.06
Surprise
+154.24%
Accendra Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.19
Surprise
-113.00%
FAQ
What were Cellectar Biosciences INC NEW's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Cellectar Biosciences INC NEW reported EPS of -$1.30, beating estimates by 32.39%, and revenue of $0.00, 0% as expectations.
How did the market react to Cellectar Biosciences INC NEW's Q1 2026 earnings?
The stock price moved up 8.84%, changed from $2.94 before the earnings release to $3.20 the day after.
When is Cellectar Biosciences INC NEW expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Cellectar Biosciences INC NEW's next earnings report?
Based on 5
analysts, Cellectar Biosciences INC NEW is expected to report EPS of -$0.49 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement